Results from a double blinded, randomised, placebo-controlled, feasibility trial of melatonin for the treatment of delirium in older medical inpatients.
Peter W LangeDaniel I Clayton-ChubbRosie WatsonAndrea B MaierPublished in: Internal medicine journal (2021)
A trial of the hypothesis that 5 mg melatonin nightly for five nights reduces delirium severity in older medical inpatients would require 120 patients, and is feasible.
Keyphrases
- study protocol
- placebo controlled
- phase iii
- clinical trial
- phase ii
- end stage renal disease
- double blind
- healthcare
- open label
- chronic kidney disease
- cardiac surgery
- ejection fraction
- physical activity
- newly diagnosed
- community dwelling
- peritoneal dialysis
- middle aged
- prognostic factors
- squamous cell carcinoma
- hip fracture
- radiation therapy
- phase ii study
- rectal cancer